跳至主要内容
临床试验/NCT00653107
NCT00653107终止3 期

Palliation of Dysphagia in Patients With Advanced Cancer of the Oesophagus by Comparing Stent Followed by 3 Courses of Brachytherapy With 3 Courses of Brachytherapy Only. A Randomised Phase III Study (PACO)

Oslo University Hospital2 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2008年6月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
终止
发起方
入组人数
41
试验地点
2
主要终点
Dysphagia measured with the dysphagia grading scale at week +2 after start of treatment. Pain at rest measured with ESAS at week +2 after start of treatment.

研究概览

简要总结

We wish to improve the swallowing function of patients with advanced cancer of the oesophagus, by carrying out a randomised clinical study in which we compare primary stenting followed by brachytherapy in the stent, 8 G x 3 with standard brachytherapy 8 Gy x 3.

The aim of the study is to investigate whether patients who receive a stent followed by brachytherapy have a better swallowing function without more pain at week +2,compared to patients who receive brachytherapy alone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must fulfill all the following criteria:
  • Histologically or cytologically verified carcinoma of the oesophagus
  • Reduced ability to swallow solid food, minimum grade 1 (see page 16)
  • Age ≥ 18 years
  • Ability to understand and answer (with or without help) the study questionnaires
  • Written informed consent received
  • A Completed questionnaire received from the patient
  • One of the following criteria must be fulfilled:
  • Advanced disease and WHO performance status ≥2
  • Advanced disease and WHO performance status 0-1 and other therapy excluded due to medical condition
  • Advanced disease and WHO performance status 0-1 and patient's preference
  • Local disease and WHO performance status ≥2 and other therapy excluded due to medical condition
  • Local disease and WHO performance status ≥2 and patient's preference

排除标准

  • Oesophageal stent already inserted
  • Endoscopic procedures not tolerated
  • Cannot have (additional) radiation therapy
  • Tumour location not suited for stent or brachytherapy (the upper 3 cm of oesophagus or major component in the cardia)

研究组 & 干预措施

B

Active Comparator

3 fractions of brachytherapy

干预措施: Brachytherapy (Radiation)

A

Experimental

Stent followed by 3 brachytherapy fractions

干预措施: Stent insertion (Procedure)

A

Experimental

Stent followed by 3 brachytherapy fractions

干预措施: Brachytherapy (Radiation)

结局指标

主要结局

Dysphagia measured with the dysphagia grading scale at week +2 after start of treatment. Pain at rest measured with ESAS at week +2 after start of treatment.

时间窗: 8 years

次要结局

  • Health related quality of life(8 years)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Cecilie Delphin Amdal

MD

Oslo University Hospital

研究点 (2)

Loading locations...

相似试验